Go to deals
Private Equity | TMT

Xomnia attracts investor Foreman Capital for its next phase of accelerated growth

October 2023 — Xomnia, a consultancy organization specialized in data science, data engineering and artificial intelligence (AI) services, has attracted investor Foreman Capital. By partnering with Foreman Capital, Xomnia will be able to execute and accelerate its current growth strategy, as well as jointly shape the company’s international ambitions through organic growth and acquisitions.

Founded in 2013, Xomnia has acquired a dominant market position as a niche partner for data and AI propositions in the Netherlands. Xomnia’s service offering includes defining data and AI strategies, building cloud data platforms and infrastructures, developing data science and analytical products, and boosting clients’ data and analytics capabilities. The Amsterdam-based company serves a broad and impressive client base of renowned Dutch corporates and strong brands.

Foreman Capital is an entrepreneurial investment company focused on growing profitable SMEs operating in a B2B environment. From its offices in Amsterdam and Copenhagen, the Foreman team has been supporting entrepreneurs, founders and family companies in realizing their growth ambitions and further professionalizing their businesses for over 25 years.

Our role in the transaction

Oaklins’ team in the Netherlands acted as the exclusive sell-side advisor to the shareholders of Xomnia. This transaction highlights Oaklins’ strong track record and expertise in the fast-moving AI sector and emphasizes our experience in TMT-related transactions.

Parties
“Our goal was to find a new partner for Xomnia that shares the same entrepreneurial core values, to bring the company to the next phase and broaden the exciting opportunities for our professionals. By leveraging their extensive industry experience and broad international network, Oaklins enabled us to find that ideal partner. The guidance and result-oriented approach from the Oaklins team has been proven exceptionally valuable throughout the entire process.”

William van Lith

Co-founder, Xomnia

Talk to the deal team

Frederik van der Schoot

Managing Partner
Amsterdam, Netherlands
Oaklins Netherlands

Jan-Pieter van Doorn

Director
Amsterdam, Netherlands
Oaklins Netherlands

Daaf Onijs

Associate
Amsterdam, Netherlands
Oaklins Netherlands

Oscar van Rijn

Associate
Amsterdam, Netherlands
Oaklins Netherlands

Related deals

Terhills Resort by Center Parcs has been acquired by TwentyTwo Real Estate
Private Equity | Consumer & Retail | Real Estate

Terhills Resort by Center Parcs has been acquired by TwentyTwo Real Estate

Terhills Resort, a premium resort in Belgium combining luxury and nature located near Hoge Kempen National Park and operated by Center Parcs, has been sold by venture capitalist LRM to TwentyTwo Real Estate, an independent real estate investor and operator. Both the real estate and the operations were included in the transaction, and Center Parcs is staying on board as an operational partner.

Learn more
Bolster Investment Partners has secured debt financing for the acquisition of Royal Taste Company
Private Equity | Food & Beverage

Bolster Investment Partners has secured debt financing for the acquisition of Royal Taste Company

Bolster Investment Partners has partnered with Royal Taste Company, a leading Dutch custom signature coffee platform offering end-to-end sourcing, blending, roasting, packaging and delivery services. The partnership marks an important next step in Royal Taste Company’s growth trajectory, focused on further geographical expansion, commercial development and selective strategic acquisitions.

Learn more
UKAT Group has acquired Bayberry Limited
Private Equity | Healthcare

UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

Learn more